Sign in

CIK 0001730430 · Large accelerated filer

Kiniksa Pharmaceuticals International, plc

Sign in to watch
Ticker
KNSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981795578
Phone
7814319100
Business address
105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
Former names
Kiniksa Pharmaceuticals, Ltd.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$78,588,440
in 8 filings, $78.6M under 10b5-1 plans

Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
  2. Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
  3. Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
  4. Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
  5. Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Date Insider Transaction Shares Price Value Owned after
2018-05-29 Flynn James E 10% owner Purchase +235,019 $19.24 $4.5M 843,352
2018-05-29 Flynn James E 10% owner Conversion · Series C Preferred Stock −383,538 0
2018-05-29 Cormorant Asset Management, LP 10% owner Conversion +830,999 830,999
2018-05-29 Cormorant Asset Management, LP 10% owner Purchase +69,444 $18.00 $1.2M 900,443
2018-05-29 Cormorant Asset Management, LP 10% owner Conversion · Series C Preferred Shares −830,999 0
2018-05-29 Patel Sanj K Chairman & CEO Conversion +135,889 245,685
2018-05-29 Patel Sanj K Chairman & CEO Conversion · Series A Preferred Shares −428,203 0
2018-05-29 Patel Sanj K Chairman & CEO Conversion · Series B Preferred Shares −71,967 0
2018-05-29 Patel Sanj K Chairman & CEO Conversion · Series C Preferred Shares −63,922 0
2018-05-29 Patel Sanj K Chairman & CEO Conversion · Class B Common Shares +428,203 1,526,160
2018-05-29 Beetham Thomas W. Chief Legal Officer Conversion +6,392 79,589
2018-05-29 Beetham Thomas W. Chief Legal Officer Conversion · Series A Preferred Shares −48,172 0
2018-05-29 Beetham Thomas W. Chief Legal Officer Conversion · Series C Preferred Shares −6,392 0
2018-05-29 Beetham Thomas W. Chief Legal Officer Conversion · Class B Common Shares +48,172 414,157
2018-05-29 Malley Thomas Director Conversion +71,967 71,967
2018-05-29 Malley Thomas Director Conversion · Series B Preferred Shares −71,967 0
2018-05-29 BOESS CARSTEN 10% owner Conversion +6,392 79,589
2018-05-29 BOESS CARSTEN 10% owner Conversion · Series A Preferred Shares −107,050 0
2018-05-29 BOESS CARSTEN 10% owner Conversion · Series C Preferred Shares −6,392 0
2018-05-29 BOESS CARSTEN 10% owner Conversion · Class B Common Shares +107,050 473,035

Page 79 of 80 · 1,595 trades